Blood- or urine-based tests for detecting abnormal levels of cancer-related proteins—e.g., carcinoembryonic antigen, prostate-specific antigen (PSA), and alpha-fetoprotein—have been used routinely for several years in the early diagnosis and monitoring of tumors [69,70]. The gene discussed is KLK3; the disease is cancer.